Ursula Busse PhD, MBA Tigen Pharma

Ursula is currently leading Regulatory Affairs for Tigen Pharma, a Swiss biotech company developing autologous T-cell therapies against cancer. Ursula joined Tigen from Boehringer-Ingelheim, where she was Head of Regulatory Intelligence & Policy. Prior to that, Ursula worked at Novartis as Global Head of Quality Intelligence & External Affairs, a role she assumed after a few years as Head of Project Office, Biopharmaceutical Operations, and Project Leader in CMC Regulatory Affairs for biotech products. Before joining Novartis in 2006, Ursula worked for startup biotech companies in Canada, in R&D, Quality Assurance and CMC Regulatory Affairs. Ursula can look back on over 20 years of volunteer engagement in several industry associations (PDA, DIA, ISPE, EFPIA) and served on PDA’s Board of Directors from 2012 to 2017. She holds a PhD in Cellular and Molecular Biology from Laval University (Québec, Canada), coupled with an MBA she earned with honours.